INVO Fertility (IVF) Interest Coverage Ratio Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34.85% |
| Jun 30, 2025 | -27.00% |
| Mar 31, 2025 | 31.18% |
| Dec 31, 2024 | 23.57% |
| Sep 30, 2024 | 60.55% |
| Jun 30, 2024 | 33.02% |
| Mar 31, 2024 | -21.13% |
| Dec 31, 2023 | -47.34% |
| Sep 30, 2023 | -6.83% |
| Jun 30, 2023 | 13.23% |
| Mar 31, 2023 | 19.55% |
| Dec 31, 2022 | 44.03% |
| Sep 30, 2022 | -114.32% |
| Jun 30, 2022 | -290.29% |
| Mar 31, 2022 | -251.43% |
| Dec 31, 2021 | 19.76% |
| Sep 30, 2021 | 16.38% |
| Jun 30, 2021 | 44.70% |
| Mar 31, 2021 | 63.76% |
| Dec 31, 2020 | -78.48% |
| Sep 30, 2020 | 37.70% |
| Jun 30, 2020 | -177.70% |
| Mar 31, 2020 | 0.48% |
| Dec 31, 2019 | 32.95% |
| Sep 30, 2019 | -128.31% |
| Jun 30, 2019 | -22.59% |
| Mar 31, 2019 | 17.07% |
| Dec 31, 2018 | 0.06% |
| Sep 30, 2018 | 28.27% |
| Jun 30, 2018 | -15.67% |
| Mar 31, 2018 | -16.22% |
| Dec 31, 2017 | 57.29% |
| Sep 30, 2017 | -20.89% |
| Jun 30, 2017 | -18.64% |
| Mar 31, 2017 | 17.11% |
| Dec 31, 2016 | -33.58% |
| Sep 30, 2016 | -57.45% |
| Jun 30, 2016 | -190.35% |